Citation: | WANG Juan, LIAO Hong. Advances in drug research and development through directed differentiation of stem cells[J]. Journal of China Pharmaceutical University, 2011, 42(3): 193-197. |
[1] | MU Yao, ZHAO Huimin, LIU Haochen, LIU Xiaoquan. Advances in drug development for Alzheimer’s disease[J]. Journal of China Pharmaceutical University, 2024, 55(6): 816-825. DOI: 10.11665/j.issn.1000-5048.2024010202 |
[2] | LU Xiao, WANG Xingru, QI Xueyong, LIAO Lianming, LIAN Yunfei. Research progress and existing problems in the industrialization of stem cell drugs[J]. Journal of China Pharmaceutical University, 2024, 55(2): 270-280. DOI: 10.11665/j.issn.1000-5048.2023111604 |
[3] | YU Zehao, ZHANG Leiming, ZHANG Mengna, DAI Zhiqi, PENG Chengbin, ZHENG Siming. Artificial intelligence-based drug development: current progress and future challenges[J]. Journal of China Pharmaceutical University, 2023, 54(3): 282-293. DOI: 10.11665/j.issn.1000-5048.2023041003 |
[4] | Gao Zhonghao. 新型药物递送系统技术在药物研发中的应用和展望[J]. Journal of China Pharmaceutical University, 2023, 54(1): 1-4. DOI: 10.11665/j.issn.1000-5048.2023030303 |
[5] | XING Xuyang, WANG Xiaochun, HE Wei. Advances in research on tumor immunotherapy and its drug development[J]. Journal of China Pharmaceutical University, 2021, 52(1): 10-19. DOI: 10.11665/j.issn.1000-5048.20210102 |
[6] | LIU Jiamin, JIA Xiaoqing, DI Bin. Application of three-dimensional cell model in tumor research[J]. Journal of China Pharmaceutical University, 2020, 51(2): 152-160. DOI: 10.11665/j.issn.1000-5048.20200204 |
[7] | ZHANG Jing. Analysis on research and development of global cardiovascular drugs in the past 6 years[J]. Journal of China Pharmaceutical University, 2018, 49(6): 760-765. DOI: 10.11665/j.issn.1000-5048.20180619 |
[8] | CHEN Yingying, LI Ruiyan, CHEN Huan, ZHANG Yubin. Development and application of drugs targeting the innate and adaptive immune system in the colon[J]. Journal of China Pharmaceutical University, 2016, 47(4): 388-396. DOI: 10.11665/j.issn.1000-5048.20160402 |
[9] | YANG Qian, MA Qiujuan, WANG Xiaojian. Suggestions for secondary innovations and generic development for drugs from the perspective of patent — taking HIV protease inhibitor lopinavir as an example[J]. Journal of China Pharmaceutical University, 2015, 46(4): 499-503. DOI: 10.11665/j.issn.1000-5048.20150419 |
[10] | ZHAO Hong-ping, JIANG Hong-min, XIANG Bing-ren. Analysis on the hot spot targets and tendency of the global cardiovascular drug development in recent 5 years[J]. Journal of China Pharmaceutical University, 2012, 43(6): 573-576. |